All In Biotech

Drug Trial Radar · NCT01289015

Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

A Phase 3 Double-Blind, Randomized, Placebo-Controlled,Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Last checked: Nov 20, 2026Latest source record: Sep 26, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 855 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

855

Actual

Start

Feb 2011

Primary completion

Nov 2011

Study completion Jan 2012

Sponsor

Lead sponsor
Merz North America, Inc.Industry
Sponsor type
Industry
First posted
Feb 3, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of NAFT-600, applied once daily for 2 weeks, when compared to placebo for 2 weeks in the treatment of subjects with tinea pedis.

Conditions

  • Tinea Pedis

Interventions

  • NAFT-600 ( naftin 2 % gel )Drug

    Topical; applied once daily for two weeks

  • PlaceboDrug

    Topical; applied once daily for two weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Cure of Interdigital Tinea PedisTime frame: Visit 4/ Week 6

Locations

23 sites in 2 countries. Site status is shown where the registry gives one.

  • Associated Foot & Ankle Specialists, LLC

    Phoenix, Arizona

  • Skin Surgery Medical Group, Inc.

    San Diego, California

  • UCSF Dermatology Research

    San Francisco, California

  • The Savin Center, PC

    New Haven, Connecticut

  • Avail Clinical Research

    DeLand, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • International Dermatology Research, Inc.

    Miami, Florida

  • Miami Dermatology Research Institute, LLC

    North Miami Beach, Florida

  • Radiant Research, Inc.

    Pinellas Park, Florida

  • Northwest Clinical Trials

    Boise, Idaho

  • Physician Skin Care

    Louisville, Kentucky

  • Michigan Center for Skin Care Research

    Clinton Township, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • Skin Search of Rochester, Inc.

    Rochester, New York

  • Crescent Medical Research

    Salisbury, North Carolina

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina

  • Paddington Testing Co., Inc.

    Philadelphia, Pennsylvania

  • Tennessee Clinical Research Center

    Nashville, Tennessee

  • DermResearch, Inc.

    Austin, Texas

  • The Center for Skin Research

    Houston, Texas

  • Endeavor Clinical Trials, PA

    San Antonio, Texas

  • Advanced Medical Concepts, PSC

    Cidra, PR, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.